Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
24-hour ambulatory blood pressure study of valsartan + levamlodipine tablets in mild to moderate essential hypertension
CTR20241533Phase 3Completed
- Sponsor
- Hemukang Pharmaceutical
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valsartan, Levamlodipine in essential hypertension, sponsored by Hemukang Pharmaceutical. Started Apr 2024; status: completed.
02
Drugs
valsartanLevamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20241533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241533.